Tactorum is a biotechnology company transforming how pain is measured in preclinical research. Our flagship product, the ARM (Automated Reproducible Mechano-stimulator) technology benefits both scientific research and patient health by closing a critical gap in how pain is measured.
For researchers, ARM provides a standardized, objective way to quantify pain responses in preclinical models, improving data quality, reproducibility, and experimental efficiency. It reduces bias, increases throughput, and enables more precise modeling of pain mechanisms—accelerating the development and testing of new therapies.
For patients, these improvements translate into faster, more reliable identification of effective treatments, especially non-opioid alternatives. By producing high-quality data with greater translational value, ARM helps ensure that preclinical findings are more likely to succeed in human clinical trials. In the long term, this leads to better pain diagnostics and targeted interventions, ultimately improving patient outcomes and quality of life.
Company Details
- Employees
- 2
- Founded
- -
- Address
- New York, New York, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://tactorum.com
- Keywords
- Pre-Clinical Pain Assay, Mechanosensory Testing, Machine Vision Behavioral Analysis, Assay Automation, Pain Research, Touch Research.
- HQ
- NEW YORK, NEW YORK
Tactorum Questions
Tactorum's website is http://tactorum.com
Tactorum's LinkedIn profile is https://www.linkedin.com/company/tactorum
Tactorum has
2 employees.
View email and phone details for 2
employees at Tactorum.
Tactorum's industry is
Biotechnology Research
Tactorum's categories are Biotechnology Research
Tactorum's founding year is 2024
